Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1
暂无分享,去创建一个
L. Truong | Y. Lou | Yuxiang Sun | A. Ross | Luping Huang | J. Pan | Huiming Ju | D. Sheikh-Hamad | Lin Zhang
[1] L. Truong,et al. AKI after conditional and kidney-specific knockdown of stanniocalcin-1. , 2014, Journal of the American Society of Nephrology : JASN.
[2] Luping Huang,et al. Overexpression of stanniocalcin-1 inhibits reactive oxygen species and renal ischemia/reperfusion injury in mice , 2012, Kidney international.
[3] May P. Xiong,et al. Non-cell-autonomous RNA interference in mammalian cells: Implications for in vivo cell-based RNAi delivery , 2011, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.
[4] V. Dixit,et al. Mitochondrial reactive oxygen species drive proinflammatory cytokine production , 2011, The Journal of experimental medicine.
[5] J. Cook,et al. The mitochondrial component of intracrine action. , 2010, American Journal of Physiology. Heart and Circulatory Physiology.
[6] F. Schena,et al. TLR2 plays a role in the activation of human resident renal stem/progenitor cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] M. Abdelrahim,et al. Stanniocalcin-1 Suppresses Superoxide Generation in Macrophages through Induction of Mitochondrial Ucp2 , 2008 .
[8] L. Truong,et al. Immunopathology and Infectious Diseases Anti-Inflammatory and Renal Protective Actions of Stanniocalcin-1 in a Model of Anti-Glomerular Basement Membrane Glomerulonephritis , 2010 .
[9] Q. Yao,et al. Human Stanniocalcin-1 Blocks TNF-&agr;–Induced Monolayer Permeability in Human Coronary Artery Endothelial Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[10] G. F. Wagner,et al. Stanniocalcin-1 secretion and receptor regulation in kidney cells. , 2008, American journal of physiology. Renal physiology.
[11] Matthew R. McReynolds,et al. Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes. , 2007, American journal of physiology. Renal physiology.
[12] Pumin Zhang,et al. A transgenic approach for RNA interference-based genetic screening in mice , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Tipping,et al. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. , 2005, Journal of the American Society of Nephrology : JASN.
[14] C. Luo,et al. Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors. , 2004, Molecular endocrinology.
[15] E. Bottinger,et al. Utility of endogenous creatinine clearance as a measure of renal function in mice. , 2004, Kidney international.
[16] D. Etemadmoghadam,et al. Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis. , 2004, American journal of physiology. Renal physiology.
[17] J. Bonventre. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. , 2003, Journal of the American Society of Nephrology : JASN.
[18] H. Weiner,et al. The importance of cell‐mediated immunity in the course and severity of autoimmune anti‐glomerular basement membrane disease in mice , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] G. F. Wagner,et al. Characterization of Mammalian Stanniocalcin Receptors , 2002, The Journal of Biological Chemistry.
[20] Jean Wu,et al. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. , 2002, The Journal of clinical investigation.
[21] C. Blobel,et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.
[22] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[23] M. Larsen,et al. Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. , 2000, The Biochemical journal.
[24] G. F. Wagner,et al. Development of a human stanniocalcin radioimmunoassay: serum and tissue hormone levels and pharmacokinetics in the rat , 2000, Molecular and Cellular Endocrinology.
[25] R. Atkins,et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. , 1999, The American journal of pathology.
[26] R. Atkins,et al. Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid Production , 1998, Molecular medicine.
[27] F. Schena. Role of growth factors in acute renal failure. , 1998, Kidney international. Supplement.
[28] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[29] P. Tipping,et al. Mechanisms of T cell‐induced glomerular injury in anti‐glomeruler basement membrane (GBM) glomerulonephritis in rats , 1997, Clinical and experimental immunology.
[30] O. Yoshie,et al. The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.
[31] H. Nomiyama,et al. Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.
[32] R. Atkins,et al. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat , 1997, The Journal of experimental medicine.
[33] Fadi G Lakkis,et al. Immunologic determinants of susceptibility to experimental glomerulonephritis: role of cellular immunity. , 1997, Kidney international.
[34] C. Martínez-A,et al. Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation , 1996, The Journal of experimental medicine.
[35] E. Bello‐Reuss,et al. Expression and function of P-glycoprotein in a mouse kidney cell line. , 1995, The American journal of physiology.
[36] J. Neugarten,et al. Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis. , 1995, Journal of the American Society of Nephrology : JASN.
[37] M. Itô,et al. Contribution of ED-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats. , 1994, Nihon Jinzo Gakkai shi.
[38] R. Atkins,et al. The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis. , 1994, Kidney international.
[39] R. Atkins,et al. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. , 1993, Kidney international.
[40] P. Tipping,et al. T lymphocyte participation in antibody-induced experimental glomerulonephritis. , 1985, Kidney international.
[41] R. Lerner,et al. THE ROLE OF ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY IN THE PATHOGENESIS OF HUMAN GLOMERULONEPHRITIS , 1967, The Journal of experimental medicine.
[42] V. Batuman,et al. Role of proximal tubules in the pathogenesis of kidney disease. , 2011, Contributions to nephrology.
[43] P. Tipping,et al. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. , 1997, Kidney international.
[44] J. Schalkwijk,et al. Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[45] R. Atkins,et al. ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis. , 1994, Kidney international.